![](https://globalhealth5050.org/wp-content/themes/global-health/covid/media/project-logo.png)
Type in a country below to view the gender-responsiveness of its COVID-19 health policies and explore the policies reviewed
Policy name: | What is COVID-shield AstraZenica? |
Issuing authority: | Ministry of Health |
Policy date: | No date |
Assessment of gender responsiveness | Gender Blind |
Reference to human rights? | No |
Reference to equity? | No |
Policy name: | Guyana COVID-19 Emergency Response Project (P175268)- Stakeholder Engagement Plan (Draft Version) - See 5. Stakeholder Engagement Program |
Issuing authority: | MOH |
Policy date: | 29 October 2020 |
Policy type: | Communications guidelines |
Assessment of gender responsiveness | Gender Sensitive |
Reference to human rights? | Yes |
Reference to equity? | Yes |
Policy name: | Interim Health and Safety Guidelines |
Issuing authority: | The Co-operative Republic of Guyana Ministry of Health and the World Bank |
Policy date: | 28 October 2020 |
Assessment of gender responsiveness | Gender Blind |
Reference to human rights? | No |
Reference to equity? | No |
Policy name: | Guyana COVID-19 Emergency Response Project (P175268)- Stakeholder Engagement Plan (Draft Version) - See Subcomponent 1.1: Case Detection Confirmation Contact Tracing Recording Reporting |
Issuing authority: | MOH |
Policy date: | 29 October 2020 |
Assessment of gender responsiveness | N |
Reference to human rights? | Yes |
Reference to equity? | Yes |
Policy name: | Guyana COVID-19 Emergency Response Project - Stakeholder Engagement Plan - Section 4.3 Disadvantaged / Vulnerable Individuals or Groups |
Issuing authority: | The Co-operative Republic of Guyana Ministry of Health and the World Bank |
Policy date: | 29 October 2020 |
Focus on sexual and reproductive health services and/or maternal health services | Sexual and reproductive health |
Assessment of gender responsiveness | Gender Sensitive |
Reference to human rights? | No |
Reference to equity? | Yes |